Literature DB >> 21045671

Comparison of corneal epitheliotrophic capacity among different human blood-derived preparations.

Elizabeth P Shen1, Fung-Rong Hu, Shyh-Chyi Lo, Yan-Ming Chen, Yi-Chen Sun, Chung-Tien Lin, Wei-Li Chen.   

Abstract

PURPOSE: To compare the corneal epitheliotrophic capacity of different human blood-derived preparations, including cord blood serum (CBS), peripheral blood serum (PBS), and fresh frozen plasma (FFP) on bovine corneal epithelial cells.
MATERIALS AND METHODS: The concentrations of epithelial growth factor, transforming growth factor β1, insulin-like growth factor 1, hyaluronic acid, fibronectin, albumin, glucose, and calcium in different human blood derivatives were evaluated using enzyme-linked immunosorbent assay or biochemical methods. Cultivated bovine corneal epithelial cells were incubated with various blood derivatives, and cell proliferation, migration, and differentiation were evaluated by colorimetric assay, Boyden chamber chemotaxis assay, wounding assay, scanning electron microscopy, and transepithelial electric resistance measurements. Wound closure was assessed using a scratch-induced directional wounding assay.
RESULTS: Of the 3 human blood derivatives evaluated, CBS had the highest concentrations of epithelial growth factor, transforming growth factor β1, and hyaluronic acid (P < 0.05). FFP had the lowest concentration of calcium and the highest concentration of glucose (P < 0.05). CBS demonstrated the highest ability to promote cellular proliferation, followed by PBS and FFP (P < 0.05). CBS was also the best in promoting cellular differentiation because scanning electron microscopy demonstrated coherent monolayers of flattened and polygonal-shaped cells with evenly distributed microvilli. Transepithelial electric resistance was noted to be the highest for cells incubated in CBS, indicating formation of well-differentiated cells with functional tight junction (P < 0.05). Cells cultivated with FFP were the least capable of promoting proliferation, migration, and differentiation.
CONCLUSIONS: Different human blood derivatives may have different concentrations of epitheliotrophic factors. CBS is generally superior to PBS in promoting corneal epithelial proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21045671     DOI: 10.1097/ICO.0b013e3181eadb67

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  11 in total

1.  Cord blood serum-based eye drops: the impact of donor haematological and obstetric factors on the variability of epidermal growth factor levels.

Authors:  Piera Versura; Marina Buzzi; Giuseppe Giannaccare; Marco Grillini; Adriana Terzi; Pasqualepaolo Pagliaro; Emilio C Campos
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

2.  Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops.

Authors:  Ronald Mauricio Sanchez-Avila; Jesus Merayo-Lloves; Ana Cristina Riestra; Luis Fernandez-Vega Cueto; Eduardo Anitua; Leire Begoña; Francisco Muruzabal; Gorka Orive
Journal:  Int Ophthalmol       Date:  2017-06-15       Impact factor: 2.031

3.  Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects.

Authors:  Elif Erdem; Meltem Yagmur; Inan Harbiyeli; Hande Taylan-Sekeroglu; Reha Ersoz
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

4.  RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing.

Authors:  Aeri Yoo; Hyun-Min Park; Soon-Suk Kang; Eun-Soon Kim; Hungwon Tchah; Jae Yong Kim
Journal:  J Vis Exp       Date:  2016-09-27       Impact factor: 1.355

5.  Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops.

Authors:  Piera Versura; Marina Buzzi; Giuseppe Giannaccare; Adriana Terzi; Michela Fresina; Claudio Velati; Emilio C Campos
Journal:  Blood Transfus       Date:  2015-07-09       Impact factor: 3.443

6.  Therapy for corneal diseases, layer by layer.

Authors:  Wei-Li Chen
Journal:  Taiwan J Ophthalmol       Date:  2017 Oct-Dec

7.  Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives.

Authors:  Chien-Jung Huang; Yi-Chen Sun; Karen Christopher; Amy Shih-I Pai; Chia-Ju Lu; Fung-Rong Hu; Szu-Yuan Lin; Wei-Li Chen
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

8.  Pigment Epithelium-Derived Factor Peptide Promotes Corneal Nerve Regeneration: An In Vivo and In Vitro Study.

Authors:  Shu-I Yeh; Sung-Hsun Yu; Hsiao-Sang Chu; Chin-Te Huang; Yeou-Ping Tsao; Chao-Min Cheng; Wei-Li Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-01-04       Impact factor: 4.799

9.  Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects.

Authors:  Bennie H Jeng; Pedram Hamrah; Ziv Z Kirshner; Benjamin C Mendez; Howard C Wessel; Larry R Brown; David L Steed
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

10.  The corneal epitheliotrophic abilities of lyophilized powder form human platelet lysates.

Authors:  Lily Wei Chen; Chien-Jung Huang; Wen-Hui Tu; Chia-Ju Lu; Yi-Chen Sun; Szu-Yuan Lin; Wei-Li Chen
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.